You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 1, January 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Multiple Sclerosis/ Demyelinating Disease
 •Transplantation, Other
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Continued Disease Activity in a Patient With Multiple Sclerosis After Allogeneic Hematopoietic Cell Transplantation

Jian-Qiang Lu, MD, PhD; Jan Storek, MD, PhD; Luanne Metz, MD; V. Wee Yong, PhD; Anne M. Stevens, MD, PhD; Richard A. Nash, MD; Jeffrey T. Joseph, MD, PhD

Arch Neurol. 2009;66(1):116-120.

Objective  To examine the effect of allogeneic hematopoietic cell transplantation (HCT) on disease activity in a patient with multiple sclerosis (MS).

Design  Case report, prospective study, and autopsy.

Setting  Departments of Clinical Neurosciences, Internal Medicine, and Pathology at the University of Calgary, Alberta, Canada.

Patient  A 39-year-old woman with chronic myelogenous leukemia and concurrent mild MS.

Interventions  Hematopoietic cell transplantation from a healthy unrelated donor.

Results  After HCT the patient developed graft-vs-host disease and experienced worsening, but not new, neurological symptoms. Her circulating leukocytes were 100% of donor origin. Magnetic resonance imaging showed increased lesion burden. She died of adenovirus hepatitis 20 weeks after HCT. An autopsy revealed demyelinating-inflammatory activity in active lesions and chronic active lesions.

Conclusion  Despite high-dose, cytotoxic, immunosuppressive therapy and exchange of a presumed autoreactive immune system with a healthy immune system, MS in this patient continued to be active.


Author Affiliations: Departments of Pathology (Drs Lu and Joseph), Internal Medicine (Dr Storek), and Clinical Neurosciences (Drs Metz and Yong), University of Calgary, Alberta, Canada; Department of Pediatrics, University of Washington and Center for Immunity and Immunotherapy, Children's Hospital Research Institute (Dr Stevens); and Fred Hutchinson Cancer Research Center, Seattle, Washington (Dr Nash).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.